Oncology Venture Sweden AB announces start of subscription period of the rights issue
Today, on January 11th, 2018, the subscription period in Oncology Venture Sweden AB´s (“Oncology Venture”) rights issue, starts. The rights issue is also open to the public. The subscription period ends on January 25th, 2018. Fully subscribed rights issue provides Oncology Venture approximately SEK 44.7 million before issuing costs. Beforehand, the company has agreed on subscription commitments amounting to approximately SEK 16.0 million, which equals about 36 % of the rights issue’s total volume and subscription guarantees amounting to approximately SEK 20.9 million, which equals about 43 %